BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 46 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,636,827 | +9.9% | 39,812,000 | +11.5% | 0.92% | +32.1% |
| Q2 2023 | $36,062,832 | +36.4% | 35,695,000 | +41.5% | 0.70% | +39.6% |
| Q1 2023 | $26,430,712 | -23.6% | 25,220,000 | -21.3% | 0.50% | -16.8% |
| Q4 2022 | $34,615,044 | +3.4% | 32,064,000 | -4.4% | 0.60% | -1.0% |
| Q3 2022 | $33,470,000 | -10.7% | 33,534,000 | -10.6% | 0.61% | -8.4% |
| Q2 2022 | $37,482,000 | -17.3% | 37,527,000 | -16.8% | 0.66% | -8.6% |
| Q1 2022 | $45,311,000 | -0.2% | 45,103,000 | +3.7% | 0.72% | -5.0% |
| Q4 2021 | $45,390,000 | -35.1% | 43,505,000 | -38.2% | 0.76% | -41.1% |
| Q3 2021 | $69,985,000 | -1.7% | 70,371,000 | -0.4% | 1.30% | -6.5% |
| Q2 2021 | $71,212,000 | – | 70,652,000 | – | 1.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 55,306,226 | $54,866,518 | 2.72% |
| MACKAY SHIELDS LLC | 76,286,000 | $74,883,901 | 2.06% |
| Sonora Investment Management Group, LLC | 10,890,000 | $10,840,075 | 0.93% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 39,812,000 | $39,636,827 | 0.92% |
| BANQUE PICTET & CIE SA | 636,000 | $63,228,545 | 0.75% |
| PIER 88 INVESTMENT PARTNERS LLC | 1,902,000 | $1,884,616 | 0.47% |
| LOOMIS SAYLES & CO L P | 2,074,551 | $183,557 | 0.32% |
| Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,015 | 0.28% |
| iA Global Asset Management Inc. | 14,690,000 | $14,625 | 0.24% |
| RATIONAL ADVISORS LLC | 1,803,000 | $1,786,052 | 0.16% |